Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT06002204

Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression

Conditions: Depression, Treatment Resistant Depression, Mood Disorders, Bipolar Disorder, Mental Disorders, Bipolar and Related Disorders

Sex: All
Ages: 10 Years – N/A
Healthy volunteers: Yes
Enrollment: 6000
Sponsor: University of Texas Southwestern Medical Center

Location: UT Southwestern Medical Center Dallas Texas

Summary

SHAKTI (from the Sanskrit word for "power") is a 5-year natural history, longitudinal, prospective study of a cohort of 6,000 participants that will help uncover the socio-demographic, lifestyle, clinical, psychological, and neurobiological factors that contribute to antidepressant treatment response (remission, recurrence, relapse and individual outcomes in depressive disorders) and resilience. As this is an exploratory study, we will assess a comprehensive panel of carefully selected participant specific parameters - socio-demographic (age, sex, gender, race, ethnicity, economic); life habits (physical activity, substance use); clinical (medical history, anxious depression, early life trauma), biological (biomarkers in blood, saliva, urine, stool), behavioral (cognitive, emotional), neurophysiological (EEG), and neuroimaging (magnetic resonance imaging; MRI) with the goal of developing the most robust predictive models of depression treatment response and of outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Adult or youth aged 10 years or older 2. Self-identify fully or partially as being of Asian or Pacific Islander descent such as: East Asian, South Asian, Southeast Asian, Southwest Asian, Central Asian, Oceanian, Pacific Islander, Polynesian, Micronesian, Melanesian 3. Have the ability to speak, read, and understand English. The parent(s) or legal guardians of minors must also speak, read and understand English. 4. Have the ability to complete clinical evaluations, neuropsychological testing, and self-report measures. 5. Meet criteria for one of these three groups: 1. Have a lifetime or a current diagnosis of a mood disorder (such as depression, bipolar disorder, anxiety) based upon a semi- structured diagnostic interview (must be a non-psychotic depressive disorder) 2. Be at risk for developing mood disorders 3. Healthy Control Group Exclusion Criteria: 1. History of schizophrenia, schizoaffective disorders or chronic psychotic disorders based upon a semi-structured diagnostic interview. 2. Unable to provide a stable home address and contact information. 3. Has any condition for which, in the opinion of the investigator or designee, study participation would not be in their best interest (including but not limited to cognitive impairment, unstable general medical condition, intoxication, active psychosis) or that could prevent, limit, or confound the protocol-specified assessments. 4. Requires immediate hospitalization for psychiatric disorder or suicidal risk as assessed by a licensed study clinician.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06002204). StuddyBuddy aggregates publicly available trial information.